Fulcrum Asset Management LLP bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm bought 5,744 shares of the medical equipment provider’s stock, valued at approximately $2,368,000.
Several other institutional investors and hedge funds have also made changes to their positions in ISRG. Main Street Group LTD purchased a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. North Point Portfolio Managers Corp OH purchased a new position in Intuitive Surgical during the third quarter worth approximately $27,000. John Boyer Inc. purchased a new position in Intuitive Surgical during the third quarter worth approximately $27,000. Compass Wealth Management LLC purchased a new position in Intuitive Surgical during the third quarter worth approximately $29,000. Finally, Evergreen Advisors LLC acquired a new position in Intuitive Surgical during the first quarter worth $35,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.
Intuitive Surgical Price Performance
Shares of NASDAQ ISRG opened at $450.04 on Wednesday. The company has a 50 day simple moving average of $413.15 and a 200-day simple moving average of $431.20. The company has a market capitalization of $156.00 billion, a P/E ratio of 51.63, a P/E/G ratio of 3.17 and a beta of 1.45. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88.
Analyst Ratings Changes
Several analysts have issued reports on the company. Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. BMO Capital Markets reiterated an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 22nd. Finally, BNP Paribas Exane raised shares of Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $493.54.
Read Our Latest Research Report on ISRG
Insider Buying and Selling
In other Intuitive Surgical news, VP Fredrik Widman sold 4,047 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total value of $1,834,140.87. Following the sale, the vice president owned 1,026 shares in the company, valued at $464,993.46. The trade was a 79.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 20,095 shares of the company’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the transaction, the director directly owned 1,204,530 shares in the company, valued at approximately $543,977,793.30. This trade represents a 1.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 39,056 shares of company stock valued at $17,585,864 in the last ninety days. Company insiders own 0.60% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
